308 related articles for article (PubMed ID: 11783749)
1. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
3. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Tanji H; Kato H; Itoyama Y
J Neurol Sci; 1998 Oct; 160(2):121-7. PubMed ID: 9849794
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.
Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
Eur Neuropsychopharmacol; 2000 Sep; 10(5):365-75. PubMed ID: 10974608
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
6. Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats.
Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
Acta Physiol Scand; 2000 May; 169(1):71-8. PubMed ID: 10759613
[TBL] [Abstract][Full Text] [Related]
7. Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation.
Araki T; Tanji H; Fujihara K; Kato H; Itoyama Y
Metab Brain Dis; 1999 Mar; 14(1):21-31. PubMed ID: 10348311
[TBL] [Abstract][Full Text] [Related]
8. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
9. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
[TBL] [Abstract][Full Text] [Related]
11. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
[TBL] [Abstract][Full Text] [Related]
12. Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Tanji H; Kato H; Mizugaki M; Itoyama Y
Eur J Pharm Sci; 1999 Aug; 8(4):261-7. PubMed ID: 10425376
[TBL] [Abstract][Full Text] [Related]
13. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
14. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Pan HS; Penney JB; Young AB
J Neurochem; 1985 Nov; 45(5):1396-404. PubMed ID: 2995585
[TBL] [Abstract][Full Text] [Related]
15. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
Smith JA; Leslie FM; Broide RS; Loughlin SE
Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
[TBL] [Abstract][Full Text] [Related]
16. Changes in the gene expression of GABA(A) receptor alpha1 and alpha2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts.
Yu TS; Wang SD; Liu JC; Yin HS
Exp Neurol; 2001 Apr; 168(2):231-41. PubMed ID: 11259111
[TBL] [Abstract][Full Text] [Related]
17. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
18. Synaptic localization of GABA(A) receptor subunits in the substantia nigra of the rat: effects of quinolinic acid lesions of the striatum.
Fujiyama F; Stephenson FA; Bolam JP
Eur J Neurosci; 2002 Jun; 15(12):1961-75. PubMed ID: 12099902
[TBL] [Abstract][Full Text] [Related]
19. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
Giorgi M; Melchiorri G; Nuccetelli V; D'Angelo V; Martorana A; Sorge R; Castelli V; Bernardi G; Sancesario G
Neurobiol Dis; 2011 Jul; 43(1):293-303. PubMed ID: 21515371
[TBL] [Abstract][Full Text] [Related]
20. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
